Stuart A. Arbuckle - 10 Feb 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, COO
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
10 Feb 2022
Net transactions value
-$722,730
Form type
4
Filing time
14 Feb 2022, 15:13:02 UTC
Previous filing
03 Feb 2022
Next filing
22 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability $722,730 -3,040 -3.8% $237.74 76,438 10 Feb 2022 Direct
holding VRTX Common Stock 140 10 Feb 2022 401(K)
* An asterisk sign (*) next to the price indicates that the price is likely invalid.